$9.99
Discover the significant changes brought by the FDA’s final order on cytomegalovirus (CMV) DNA quantitative assay devices for transplant patient management. Learn about the implications of reclassification from class III to class II, including special controls and the premarket notification requirement, and how these changes impact compliance, safety, and effectiveness.
In this course you will learn the following:
* Understand the regulatory background and rationale for the reclassification of CMV transplant assays.
* Identify the key requirements and special controls associated with class II devices.
* Recognize the steps necessary for compliance with the new classification.
* Comprehend the consequences of non-compliance with the reclassification order.
NOTE: Unless otherwise indicated, all course purchases are for access to the course for a period of 1-year. At the end of the one year term, the course will be set to “inactive”.
Why This Course is Important
Failing to stay updated on the FDA’s reclassification could lead to non-compliance and jeopardize the safety and effectiveness of CMV DNA quantitative assay devices in transplant patient management.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Microbiology Devices; Reclassification of Cytomegalovirus Deoxyribonucleic Acid Quantitative Assay Devices Intended for Transplant Patient Management.
Key regulatory references include:
Course SKU
FR-24-214-1
CourseAvenue eLearning Platform has helped Federal agencies (and their suppliers) successfully address their most complex eLearning accessibility challenges.
Federal Register Title
This benchmark will help determine your readiness for: Federal Register Document titled Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update. Document Number: 2026-06675
Buy this Course
FR-26-1848-1
Why This Course is Important
Without this course, you may miss important details on payment updates, new reporting requirements, and potential financial and compliance impacts for inpatient psychiatric facilities under Medicare in FY 2027.
Course Details
This is a self-paced eLearning course based on the Federal Register Document titled Medicare Program; FY 2027 Inpatient Psychiatric Facilities Prospective Payment System-Rate Update.
Key regulatory references include:
Course SKU
FR-26-1848-1
© 2026 CourseAvenue, LLC | All rights reserved.
